USPTO Examiner COLEMAN CHARLES P - Art Unit 3626

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18432350DISTRIBUTED COMPUTING SYSTEM FOR BLOOD PROCESSING PROCEDURESFebruary 2024August 2024Allow610NoNo
18339455PHARMACEUTICAL PACKAGING AND METHOD FOR DELIVERY OF SAMEJune 2023September 2024Abandon1510NoNo
18134973REAL-TIME ECG REPORT GENERATIONApril 2023May 2024Allow1320YesYes
18183763Dynamically Controlled Treatment Protocols for Autonomous Treatment SystemsMarch 2023February 2024Allow1100NoNo
18093144CARE PLAN ADMINISTRATION: PATIENT FEEDBACKJanuary 2023January 2024Allow1210YesNo
17959923SYSTEM FOR IMMUTABILITY VERIFYING, RECORDING AND STORING DIGITAL REPRESENTATION OF OBJECTS AND EVENTSOctober 2022March 2024Abandon1720NoNo
17958289Novel Topical TherapySeptember 2022December 2023Abandon1410NoNo
17900624MANAGEMENT AND TRACKING OF PATIENT ENCOUNTERS AND MEDICAL INFORMATION INCLUDING IMMUTABLE TOKENS, DIGITAL ASSETS AND SMART CONTRACTSAugust 2022December 2023Abandon1520YesNo
17838146NON-INVASIVE DETERMINATION OF LIKELY RESPONSE TO ANTI-INFLAMMATORY THERAPIES FOR CARDIOVASCULAR DISEASEJune 2022June 2023Allow1320YesNo
17838147NON-INVASIVE DETERMINATION OF LIKELY RESPONSE TO ANTI-DIABETIC THERAPIES FOR CARDIOVASCULAR DISEASEJune 2022July 2023Allow1320YesNo
17706423DATA ABSTRACTION SYSTEM ARCHITECTURE NOT REQUIRING INTEROPERABILITY BETWEEN DATA PROVIDERSMarch 2022May 2024Allow2500NoNo
17697253METHODS AND SYSTEMS FOR REDUCING OPIOIDS FROM PAIN REGIMENS BY GRADUALLY REPLACING THE OPIOID DOSES WITH CANNABINOIDSMarch 2022January 2024Abandon2230YesNo
17579804Personalizing the Experience for the Senior Living Resident Through Automated Data Collection, Workflow Tools, and Actionable InsightsJanuary 2022February 2024Abandon2540YesNo
17573050DEVICES, SYSTEMS, AND METHODS FOR ADHERENCE MONITORING AND PATIENT INTERACTIONJanuary 2022November 2023Allow2210YesNo
17572103DEVICES, SYSTEMS, AND METHODS FOR ADHERENCE MONITORING AND PATIENT INTERACTIONJanuary 2022November 2023Allow2210YesNo
17541606SYSTEMS AND METHODS FOR SELECTING AN INTERVENTION BASED ON EFFECTIVE AGEDecember 2021January 2024Allow2510YesNo
17514303METHODS AND SYSTEMS FOR INFORMING PRODUCT DECISIONSOctober 2021January 2024Allow2610YesNo
17477745AUTOMATED IDENTIFICATION OF POTENTIAL DRUG SAFETY EVENTSSeptember 2021December 2023Abandon2610NoNo
17461353METHOD AND SYSTEM FOR DESCRIBING AND RECOMMENDING OPTIMAL TREATMENT PLANS IN ADAPTIVE TELEMEDICAL OR OTHER CONTEXTSAugust 2021April 2024Allow3100NoNo
17366791COMPUTERIZED SYSTEM AND METHOD FOR MODIFYING COMPONENTS OF HEALTHCARE ORDERS WHICH ARE ASSOCIATED INTO CROSS-PHASE GROUPSJuly 2021June 2024Allow3520YesNo
17354882DISTRIBUTED COMPUTING SYSTEM FOR BLOOD PROCESSING PROCEDURESJune 2021April 2024Allow3320NoNo
17315013CODE CART AND CODE CART SYSTEMMay 2021June 2024Abandon3820NoNo
17206915SYSTEM AND METHOD FOR FUSING CLINICAL AND IMAGE FEATURES FOR COMPUTER-AIDED DIAGNOSISMarch 2021December 2023Abandon3210NoNo
17174092Genetic Based Health Management Systems for Weight and Nutrition ControlFebruary 2021June 2024Abandon4020NoNo
17162424SYSTEM, APPARATUS AND METHOD FOR SYNCHRONIZING DOSING EVENTS BETWEEN SPACESJanuary 2021March 2024Abandon3830YesNo
17139995COMPUTER-IMPLEMENTED SYSTEM AND METHOD FOR TRACKING ENTITY LOCATIONDecember 2020May 2024Abandon4020NoNo
17130873INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND SYSTEMDecember 2020March 2024Abandon3920YesNo
17128574TELEMEDICINE STETHOSCOPE DEVICEDecember 2020April 2024Abandon3920NoNo
17108793SYSTEMS AND METHODS FOR MANAGING REGIMEN ADHERENCEDecember 2020July 2023Abandon3110YesNo
16953256Dynamic Behavioral Phenotyping for Predicting Health OutcomesNovember 2020July 2023Abandon3210NoNo
17099569COMPUTER-IMPLEMENTED SYSTEM AND METHOD FOR TRACKING PATIENT LOCATIONNovember 2020September 2024Abandon4640YesNo
17086233Patient Outcome-Based Data StoreOctober 2020April 2023Abandon3010NoNo
17068601DIGITAL PASS VERIFICATION SYSTEMS AND METHODSOctober 2020January 2022Abandon1520YesNo
17031013PHARMACEUTICAL PACKAGING AND METHOD FOR DELIVERY OF SAMESeptember 2020June 2023Abandon3310NoNo
17026239METHODS FOR ADMINISTERING RESIDENTIAL CARE FACILITYSeptember 2020December 2022Abandon2740YesNo
17015007Topical TherapySeptember 2020November 2022Abandon2710NoNo
17007004DYNAMICALLY CONTROLLED TREATMENT PROTOCOLS FOR AUTONOMOUS TREATMENT SYSTEMSAugust 2020December 2022Allow2700NoNo
16997287System and Method for Determining Operation of a Medical DeviceAugust 2020September 2023Abandon3720NoNo
16995782System and Method for Screening Potential Test Subjects for Participation in Recent TrialsAugust 2020September 2022Allow2500NoNo
16944771METHODS FOR USING TEMPORARY INFORMATIONAL MARKINGSJuly 2020January 2023Abandon3010NoNo
16937998MONITORING, CAPTURING, MEASURING AND ANNOTATING PHYSIOLOGICAL WAVEFORM DATAJuly 2020August 2024Abandon4840YesNo
16947080IDENTIFICATION OF SURGERY CANDIDATES USING NATURAL LANGUAGE PROCESSINGJuly 2020August 2023Abandon3720NoYes
16932659SYSTEMS AND METHODS FOR GENERATING OPTIMIZED SET OF PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) PARAMETERSJuly 2020March 2024Abandon4440YesNo
16926149DATA ABSTRACTION SYSTEM ARCHITECTURE NOT REQUIRING INTEROPERABILITY BETWEEN DATA PROVIDERSJuly 2020February 2022Allow1920YesNo
16920836METHODS FOR ADMINISTERING RESIDENTIAL CARE FACILITYJuly 2020August 2022Abandon2540YesNo
16916946METHOD AND SYSTEM FOR REMOTE HEALTH MONITORING, ANALYZING, AND RESPONSEJune 2020February 2024Abandon4330NoNo
16957261SIGNAL-PROCESSING DEVICE, ANALYSIS SYSTEM, SIGNAL-PROCESSING METHOD, AND SIGNAL-PROCESSING PROGRAMJune 2020December 2023Abandon4220YesNo
16874353CARE PLAN ADMINISTRATION: PATIENT FEEDBACKMay 2020September 2022Allow2810NoNo
15931517Medication Management Among A Network of Medical EntitiesMay 2020September 2023Abandon4020NoNo
15931402ESTIMATING IMPACT OF PROPERTY ON INDIVIDUAL HEALTH - PROPERTY SCOREMay 2020November 2022Allow3110NoNo
16856985METHOD AND SYSTEM FOR DESCRIBING AND RECOMMENDING OPTIMAL TREATMENT PLANS IN ADAPTIVE TELEMEDICAL OR OTHER CONTEXTSApril 2020March 2021Allow1020YesNo
16784061SYSTEM FOR ADMINISTERING A MEDICAMENTFebruary 2020December 2022Allow3410NoNo
16774418THERAPY PROGRAM SELECTION FOR ELECTRICAL STIMULATION THERAPY BASED ON A VOLUME OF TISSUE ACTIVATIONJanuary 2020January 2023Allow3610NoNo
16733156CLINICAL DASHBOARD FOR MEDICAL DEVICEJanuary 2020March 2023Abandon3820YesNo
16729326METHODS AND SYSTEMS FOR INFORMING PRODUCT DECISIONSDecember 2019September 2021Allow2020NoYes
16701196METHOD OF PREDICTING AND MITIGATING ADVERSE EVENTSDecember 2019May 2021Allow1710NoNo
16684513NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM STORING ALLERGY PRESCRIPTION SEARCH PROGRAMNovember 2019January 2023Abandon3820NoNo
16657457SYSTEMS AND METHODS FOR MEDICATION ADHERENCEOctober 2019February 2024Abandon5240YesNo
16565383SYSTEMS AND METHODS OF MONITORING MEDICATION COMPLIANCESeptember 2019November 2022Abandon3910NoNo
16558502SYSTEMS AND METHODS FOR SELECTING AN INTERVENTION BASED ON EFFECTIVE AGESeptember 2019September 2021Allow2420YesNo
16449228DATA ABSTRACTION SYSTEM ARCHITECTURE NOT REQUIRING INTEROPERABILITY BETWEEN DATA PROVIDERSJune 2019September 2020Abandon1520YesNo
16439077SYSTEMS FOR MAKING PERSONALIZED MEDICINEJune 2019April 2023Abandon4620YesNo
16396835IDENTIFICATION OF SURGERY CANDIDATES USING NATURAL LANGUAGE PROCESSINGApril 2019February 2022Abandon3340NoYes
16387291HEALTH-CARE E-COMMERCE SYSTEMS AND METHODSApril 2019May 2021Abandon2510NoNo
16374648DENTAL CONDITION EVALUATION AND TREATMENTApril 2019May 2023Abandon4960YesNo
16363337ADAPTING THE DISPLAY OF PATIENT DATA BASED ON DISPLAY SCREEN-REAL ESTATE AND PATIENT MONITORING CONTEXTMarch 2019April 2023Abandon4920YesNo
16360061AUTOMATED IDENTIFICATION OF POTENTIAL DRUG SAFETY EVENTSMarch 2019January 2022Abandon3420YesNo
16360577PATIENT CARE INTEGRATION SYSTEM AND METHODSMarch 2019January 2024Abandon5820YesYes
16360747System and Method for Assessing Heart Health and Communicating the Assessment to a PatientMarch 2019September 2022Abandon4210NoNo
16332826CONTROLLING CLOUD-BASED IMAGE PROCESSING BY ASSURING DATA CONFIDENTIALITYMarch 2019December 2021Allow3320YesNo
16352720AUTOMATED ADAPTATION OF PATIENT ASSESSMENT REPORT FORMATMarch 2019November 2021Abandon3210YesNo
16351303Data Management for Genetic Laboratory TestingMarch 2019May 2024Abandon6060YesNo
16351091DIGITAL BIOMARKERS FOR PROGRESSING MSMarch 2019April 2022Allow3720YesNo
16299077HEALTHCARE PRESCRIPTION DELIVERY TECHNIQUES USING A MONEY TRANSFER NETWORKMarch 2019September 2020Abandon1810NoNo
16294477RECORDING MEDIUM RECORDING SIMILAR CASE RETRIEVAL PROGRAM, INFORMATION PROCESSING APPARATUS, AND SIMILAR CASE RETRIEVAL METHODMarch 2019May 2021Abandon2610NoNo
16288929COGNITIVE ANALYSIS PROCESSING TO FACILITATE SCHEDULE PROCESSING AND SUMMARIZATION OF ELECTRONIC MEDICAL RECORDSFebruary 2019January 2024Abandon5860YesNo
16284704System and Method for Using Decision Rules to Identify and Abstract Data from Electronic Health SourcesFebruary 2019March 2021Abandon2510NoNo
16277330MEDICAL DOCUMENT CREATION SUPPORT APPARATUS, METHOD, AND PROGRAMFebruary 2019February 2023Abandon4840YesNo
16276507Computing Devices with Improved User Interfaces for ApplicationsFebruary 2019February 2021Abandon2410NoNo
16325489SYSTEM AND METHOD FOR DIAGNOSING AND ASSESSING THERAPEUTIC EFFICACY OF MENTAL DISORDERSFebruary 2019June 2023Abandon5240YesNo
16325646KNOWLEDGE DISCOVERY FROM SOCIAL MEDIA AND BIOMEDICAL LITERATURE FOR ADVERSE DRUG EVENTSFebruary 2019February 2021Abandon2410NoNo
16324959METHOD OF EVALUATING THERAPEUTIC EFFECT OF DRUG IN CANCER PATIENT, METHOD OF GENERATING EVALUATION DATA OF THERAPEUTIC EFFECT, THERAPEUTIC EFFECT EVALUATION DEVICE, AND THERAPEUTIC EFFECT EVALUATION PROGRAMFebruary 2019January 2024Abandon5960YesNo
16273475METHODS AND SYSTEMS FOR PREDICTING CLINICAL TRIAL CRITERIA USING MACHINE LEARNING TECHNIQUESFebruary 2019December 2022Abandon4640YesNo
16268575SYSTEM AND METHOD FOR STORING AND DELIVERING HEALTHCARE INFORMATICS DATAFebruary 2019February 2021Abandon2510NoNo
16227773SYSTEM AND METHOD FOR IMPROVING HEALTHCARE THROUGH SOCIAL ROBOTICSDecember 2018January 2021Allow2510NoNo
16350547Dynamic balance adjustment estimator engineDecember 2018May 2023Abandon5360YesNo
16185245METHOD, APPARATUS AND SYSTEM FOR RENDERING AND DISPLAYING MEDICAL IMAGESNovember 2018February 2021Abandon2710NoNo
16176150METHOD AND MOBILE APPLICATION FOR OPTIMIZING INFANT FEEDING PLANOctober 2018July 2021Abandon3320NoNo
16176691Unsaleable Pharmaceutical Item Handling and Disposal Systems, Methods, and DevicesOctober 2018February 2021Abandon2710NoNo
16173619SYSTEM AND METHOD FOR GENERATING A CARE SERVICES COMBINATION FOR A USEROctober 2018October 2021Abandon3620YesYes
16170775SYSTEMS AND METHODS FOR MEDICAL INSTRUMENT PATIENT MEASUREMENTSOctober 2018February 2021Abandon2740NoYes
16143160METHOD AND APPARATUS FOR MONITORING MEDICATION ADHERENCESeptember 2018November 2022Abandon5030YesNo
16080613Connected Healthcare EnvironmentAugust 2018April 2024Abandon6020NoYes
16059967AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND METHODAugust 2018November 2022Abandon5140YesYes
16066229METHOD AND APPARATUS FOR MONITORING A SUBJECTJune 2018July 2021Abandon3620NoNo
16061401DEVICE, SYSTEM, AND METHOD FOR OPTIMIZING A HEALTHCARE NETWORKJune 2018December 2021Abandon4220NoNo
15977690SYSTEMS AND METHODS FOR MANAGING DATA PRIVACYMay 2018August 2020Abandon2740YesNo
15959558SYSTEM AND METHOD FOR DISPLAYING DISCHARGE INSTRUCTIONS FOR A PATIENTApril 2018November 2020Abandon3010NoNo
15769756INTEGRATED HEALTHCARE PERFORMANCE ASSESSMENT TOOL FOCUSED ON AN EPISODE OF CAREApril 2018August 2023Abandon6040YesYes
15955084Pharmaceutical Packaging and Method for Delivery of SameApril 2018December 2020Abandon3210NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner COLEMAN, CHARLES P..

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
54
Examiner Affirmed
43
(79.6%)
Examiner Reversed
11
(20.4%)
Reversal Percentile
33.8%
Lower than average

What This Means

With a 20.4% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
137
Allowed After Appeal Filing
21
(15.3%)
Not Allowed After Appeal Filing
116
(84.7%)
Filing Benefit Percentile
18.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 15.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner COLEMAN, CHARLES P. - Prosecution Strategy Guide

Executive Summary

Examiner COLEMAN, CHARLES P. works in Art Unit 3626 and has examined 491 patent applications in our dataset. With an allowance rate of 13.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 50 months.

Allowance Patterns

Examiner COLEMAN, CHARLES P.'s allowance rate of 13.0% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by COLEMAN, CHARLES P. receive 3.33 office actions before reaching final disposition. This places the examiner in the 92% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by COLEMAN, CHARLES P. is 50 months. This places the examiner in the 6% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +17.9% benefit to allowance rate for applications examined by COLEMAN, CHARLES P.. This interview benefit is in the 60% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 2.3% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 7.7% of cases where such amendments are filed. This entry rate is in the 8% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 61.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 51% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 37.2% of appeals filed. This is in the 6% percentile among all examiners. Of these withdrawals, 46.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 53.5% are granted (fully or in part). This grant rate is in the 54% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 34% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 37% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.